Literature DB >> 28898690

When LMO1 Meets MYCN, Neuroblastoma Is Metastatic.

Zhihui Liu1, Carol J Thiele2.   

Abstract

LMO1 is a high-risk neuroblastoma susceptibility gene, but how LMO1 cooperates with MYCN in neuroblastoma tumorigenesis is unclear. In this issue of Cancer Cell, Zhu et al. develop a novel zebrafish model that elucidates a mechanism by which LMO1 and MYCN synergistically initiate neuroblastoma and contribute to metastatic disease progression. Published by Elsevier Inc.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28898690      PMCID： PMC6294297          DOI： 10.1016/j.ccell.2017.08.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

Review 1.  Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell.

Authors:  Herbert M Kagan; Wande Li
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

2.  Lysyl oxidase is essential for hypoxia-induced metastasis.

Authors:  Janine T Erler; Kevin L Bennewith; Monica Nicolau; Nadja Dornhöfer; Christina Kong; Quynh-Thu Le; Jen-Tsan Ashley Chi; Stefanie S Jeffrey; Amato J Giaccia
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.

Authors:  Shizhen Zhu; Jeong-Soo Lee; Feng Guo; Jimann Shin; Antonio R Perez-Atayde; Jeffery L Kutok; Scott J Rodig; Donna S Neuberg; Daniel Helman; Hui Feng; Rodney A Stewart; Wenchao Wang; Rani E George; John P Kanki; A Thomas Look
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

4.  Integrative genomics identifies LMO1 as a neuroblastoma oncogene.

Authors:  Kai Wang; Sharon J Diskin; Haitao Zhang; Edward F Attiyeh; Cynthia Winter; Cuiping Hou; Robert W Schnepp; Maura Diamond; Kristopher Bosse; Patrick A Mayes; Joseph Glessner; Cecilia Kim; Edward Frackelton; Maria Garris; Qun Wang; Wendy Glaberson; Rosetta Chiavacci; Le Nguyen; Jayanti Jagannathan; Norihisa Saeki; Hiroki Sasaki; Struan F A Grant; Achille Iolascon; Yael P Mosse; Kristina A Cole; Hongzhe Li; Marcella Devoto; Patrick W McGrady; Wendy B London; Mario Capasso; Nazneen Rahman; Hakon Hakonarson; John M Maris
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

Review 5.  Recent advances in neuroblastoma.

Authors:  John M Maris
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

Review 6.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

7.  LMO1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.

Authors:  Shizhen Zhu; Xiaoling Zhang; Nina Weichert-Leahey; Zhiwei Dong; Cheng Zhang; Gonzalo Lopez; Ting Tao; Shuning He; Andrew C Wood; Derek Oldridge; Choong Yong Ung; Janine H van Ree; Amish Khan; Brittany M Salazar; Edroaldo Lummertz da Rocha; Mark W Zimmerman; Feng Guo; Hong Cao; Xiaonan Hou; S John Weroha; Antonio R Perez-Atayde; Donna S Neuberg; Alexander Meves; Mark A McNiven; Jan M van Deursen; Hu Li; John M Maris; A Thomas Look
Journal:  Cancer Cell       Date:  2017-08-31       Impact factor: 31.743

8.  Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

Authors:  Derek A Oldridge; Andrew C Wood; Nina Weichert-Leahey; Ian Crimmins; Robyn Sussman; Cynthia Winter; Lee D McDaniel; Maura Diamond; Lori S Hart; Shizhen Zhu; Adam D Durbin; Brian J Abraham; Lars Anders; Lifeng Tian; Shile Zhang; Jun S Wei; Javed Khan; Kelli Bramlett; Nazneen Rahman; Mario Capasso; Achille Iolascon; Daniela S Gerhard; Jaime M Guidry Auvil; Richard A Young; Hakon Hakonarson; Sharon J Diskin; A Thomas Look; John M Maris
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

Review 9.  Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations.

Authors:  Kristopher R Bosse; John M Maris
Journal:  Cancer       Date:  2015-11-05       Impact factor: 6.860

Review 10.  LIM-domain-only proteins in cancer.

Authors:  Jacqueline M Matthews; Krystal Lester; Soumya Joseph; David J Curtis
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716
  10 in total
  1 in total

1.  Prognostic Signature of Immune Genes and Immune-Related LncRNAs in Neuroblastoma: A Study Based on GEO and TARGET Datasets.

Authors:  Xiaodan Zhong; Ying Tao; Jian Chang; Yutong Zhang; Hao Zhang; Linyu Wang; Yuanning Liu
Journal:  Front Oncol       Date:  2021-03-09       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.